📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Bi-specific CAR-iNKT cell immunotherapy for high-risk KMT2A-rearranged leukemia outperforms CAR-T in an NKG2D-dependent manner and eradicates leptomeningeal disease (2025)

First Author: Ren H

Attributed to: Human Developmental Biology Resource (HDBR): meeting new trends and challenges in developmental biobanking funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2025.01.22.633541

Publication URI: http://dx.doi.org/10.1101/2025.01.22.633541

Type: Preprint